Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c01022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Mei Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, P. R. China. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, Department of Science and Technology of Shandong Province, Taishan Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Hepatitis B virus (HBV) capsid assembly modulators (CAMs) represent a promising therapeutic approach for the treatment of HBV infection. In this study, we designed and synthesized five series of benzamide derivatives based on a multisite-binding strategy at the tolerant region and diversity modification in the solvent-exposed region. Among them, thioureidobenzamide compound 17i exhibited significantly increased anti-HBV activity in HepAD38 (EC50 = 0.012 μM) and HBV-infected HLCZ01 cells (EC50 = 0.033 μM). Moreover, 17i displayed a better inhibitory effect on the assembly of HBV capsid protein compared with NVR 3-778 and a inhibitory effect similar to the clinical drug GLS4. In addition, 17i showed moderate metabolic stability in human microsomes, had excellent oral bioavailability in Sprague-Dawley (SD) rats, and inhibited HBV replication in the HBV carrier mice model, which could be considered as a promising candidate drug for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Weifang Medical University, Weifang 261053, Shandong, P. R. China.
- Key Laboratory for Experimental Teratology of Ministry of Education, Key Laboratory of Infection and Immunity of Shandong Province and Dept. Immunology, School of Basic Medical Sciences, Qilu Hospital, Cheeloo Medical C…
- State Key Laboratory of Anti-Infective Drug Development (NO. 2015DQ780357), Sunshine Lake Pharma Co., Ltd, Dongguan 523871, P. R. China.
- School of Public Health, Weifang Medical University, Weifang 261053, Shandong, P. R. China.
- Department of Pharmacy, Affiliated Hospital of Jining Medical University, Jining 272000, Shandong, P. R. China.
- Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou 510000, Guangdong, P. R. China.
ORCID-Profile: Mei Wang, Haiyong Jia
Förderung
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
- Department of Science and Technology of Shandong Province
- Taishan Scholar Foundation of Shandong Province
- Weifang Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, M., Zhang, J., Dou, Y., Liang, M., Xie, Y., Xue, P., Liu, L., Li, C., Wang, Y., Tao, F., Zhang, X., Hu, H., Feng, K., Zhang, L., Wu, Z., Chen, Y., Zhan, P., & Jia, H. (2023). Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01022
Vancouver
Wang M, Zhang J, Dou Y, Liang M, Xie Y, Xue P, et al. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01022
BibTeX
@article{Wang2023,
author = {Wang, Mei and Zhang, Jian and Dou, Yutong and Liang, Minghui and Xie, Yong and Xue, Peng and Liu, Linyue and Li, Chuanju and Wang, Yuanze and Tao, Feiyan and Zhang, Xiaohui and Hu, Huili and Feng, Kairui and Zhang, Lei and Wu, Zhuanchang and Chen, Yunfu and Zhan, Peng and Jia, Haiyong},
title = {Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c01022}
}
EUVIMED